Mikhail Blagosklonny Study on Cancer and Ageing

Mikhail Blagosklonny is a specialist who studies aging and cancer. Currently, he is a professor at the Roswell Park Cancer Institute where he teaches oncology. Blagosklonny trained at the first Pavlov State Medical University of St. Petersburg where he got his Ph.D. and M.D in experimental medicine and cardiology. In 2002, New York medical college hired Mikhail as an associate professor of medicine. He then later joined Ordway Research Institute as the senior scientist. He stayed at the institute until 2009 when Roswell Park Cancer Institute appointed him as the professor of oncology.

Mikhail has had an interest in several studies in his career such as cancer whereby he examines targeted cancer therapies that keep healthy cells from damage by radioactive rays and chemotherapy, aging and anti-aging treatments. His other pursuits also include clinical investigations, cellular and molecular biology. His current studies include anti-cancer therapeutics, signal transduction, cell cycle and cellular senescence. View more articles at impactjournals.com.

Motivated by his enthusiasm in cancer and aging, Mikhail Blagosklonny postulated a hypothesis about the likely role of TOR in cancer and aging. He asserted that rapamycin, a popular drug for cancer could be a potential remedy for extension of life.

Mikhail Blagosklonny is a chief writer in cell cycle and aging. Moreover, he is a junior editor of biology and cancer therapy. He is also the co-founder and chief editor of cell death and differentiation, cancer research, American Journal of Pathology, Autophagy and International journal of cancer. Oncotarget is a weekly journal that was launched in 2010 and covers oncology research. He has more than 170research articles to his name.

Mikhail Blagosklonny joined the institution on April 15, 2009. Every member of the Institute was enthusiastic about his appointment. At Roswell Institute, the Specialists share opinions and possible approaches to curbing cancer. These ideas include how cancer can be prevented and slow down aging and also issue specific therapy of cancer. As stated in Impact Journals, Mikhail Blagosklonny has helped in facilitating the advancement of fresh anti-cancer techniques and procedures and various cancer prevention and treatment plans. View his LinkedIn profile to know more.

He has been able to achieve all the above due to his approaches and ideas that include protecting healthy body cells from chemo- and radiotherapy, tissue-specific and anti-tissue therapy, anticancer drugs particular combination and the slowdown of cancer by decreasing the aging process in organisms.